Idexx Laboratories (IDXX) Cash from Investing Activities (2009 - 2026)

Idexx Laboratories has reported Cash from Investing Activities for 18 years, with the latest figure at -$25.5 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 24.18% year-over-year to -$25.5 million in Q2 2026; TTM through Jun 2026 was -$132.0 million, a 1.22% decrease from a year earlier, with the FY2025 full-year figure at -$136.2 million, up 34.2% from the prior year.
• Cash from Investing Activities was -$25.5 million for Q2 2026 at Idexx Laboratories, up from -$33.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$25.5 million in Q2 2026, with the low at -$106.9 million in Q1 2024.
• Average Cash from Investing Activities over 5 years is -$40.2 million, with a median of -$33.6 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities slumped 170.67% in 2024, then jumped 72.31% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$49.2 million in 2022, then soared by 38.18% to -$30.4 million in 2023, then slumped by 30.91% to -$39.8 million in 2024, then grew by 29.4% to -$28.1 million in 2025, then advanced by 9.36% to -$25.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$25.5 million (Q2 2026), -$33.5 million (Q1 2026), and -$28.1 million (Q4 2025), per Business Quant data.